Meta Stock Is Getting Hit Hard. But Where Will It Be in 3 Years?

Meta’s first-quarter revenue rose 33% year over year to $56.3 billion, with advertising revenue up 33% to $55 billion and ad impressions up 19% alongside a 12% higher average price per ad. However, 2026 capital expenditure guidance was raised to $125 billion-$145 billion, nearly double 2025 spending, and Reality Labs losses remain a major drag, keeping the stock’s three-year outlook highly dependent on AI monetization and spending discipline. The article frames Meta as a wide-range outcome stock, potentially trading anywhere from the mid-$500s to around $1,000.

Analysis

The market is treating Meta less like a growth compounder and more like a capital allocation story, which is why the stock can lag even while the core ads engine reaccelerates. The key second-order effect is that AI is not just improving engagement; it is also raising the internal hurdle rate for every dollar of incremental capex, because investors now need evidence that infrastructure spending converts into durable marginal ROIC rather than just higher depreciation and operating leverage later.

That creates a notable cross-current for suppliers. If Meta keeps leaning into memory-heavy AI infrastructure, the beneficiaries are not just the obvious semiconductor names but also the memory and networking stack, while any disappointment in spend efficiency would quickly rotate the market from "AI beneficiaries" to "AI overbuild". The biggest near-term catalyst is not revenue growth itself, but whether management can frame a credible moderation path for 2027 capex without signaling an innovation slowdown.

The contrarian read is that consensus may be underestimating how much optionality Meta has if it decides to slow the build-out. Because the ad business is still throwing off very high cash conversion, the company can effectively toggle between offense and margin defense depending on macro conditions. That means the stock’s downside is likely more tied to multiple compression than to an earnings collapse, while upside requires proof that AI spend is monetizing faster than the market expects over the next 6-12 months.

For investors, the cleanest setup is a time-horizon mismatch: the business can improve quarter by quarter, but the stock may remain hostage to capex skepticism until there is evidence of better unit economics. Regulatory noise is a separate event risk, but the larger issue is whether the market decides this is a disciplined platform investment or a recurring reinvestment sink. Three years out, the valuation outcome will be driven more by spend discipline than by ad growth alone.

Key Decisions for Investors

• Buy META on a staged basis over the next 2-4 weeks, but size it as a capital-allocation trade rather than a pure growth long; target 15-20% upside if management signals even modest capex normalization, with 10-12% downside if the market re-rates the multiple below current levels.
• Pair trade: long META / short SNAP for 3-6 months. META is monetizing AI into actual ad performance, while SNAP remains more exposed to ad cyclical weakness and has less balance-sheet flexibility; this isolates platform-share gains from macro ad volatility.
• If looking for cleaner AI infrastructure exposure, prefer NVDA over META on weakness: META’s spend is an investment decision with uncertain payback, while NVDA monetizes the capex cycle directly. Use META as the funded short against NVDA only if capex intensity keeps rising into the next guidance update.
• Consider a call spread on META 6-9 months out rather than common stock if entry occurs before the next earnings print. The asymmetry is that a credible capex pause or buyback acceleration could re-rate the stock quickly, but outright equity has more downside if sentiment stays focused on spending.
• Avoid chasing after any post-earnings gap higher unless management explicitly lowers the 2027 capex trajectory; without that, upside may be capped near prior resistance because investors will keep discounting future free-cash-flow dilution.